Results 91 to 100 of about 10,913 (208)

Methimazole-induced insulin autoimmune syndrome

open access: yes, 2016
Background: Hypoglycemia in a critical care setting is often multifactorial with iatrogenic insulin use, sulfonylurea (SU) use, sepsis, adrenal insufficiency and insulinoma among the common causes.
Nidhi Jain   +3 more
core   +1 more source

Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracil

open access: yesEndocrine Journal
Agranulocytosis is a serious adverse effect of methimazole (MMI) and propylthiouracil (PTU), and although there have been reports suggesting a dose-dependent incidence in relation to both drugs, the evidence has not been conclusive.
Jaeduk Yoshimura Noh   +14 more
doaj   +1 more source

The Comparison of Catalytic Activity of Carbimazole and Methimazole on Electroreduction of Zinc (II) in Chlorates (VII): Experimental and Molecular Modelling Study

open access: yesMolecules
With the help of electrochemical methods, including CV and EIS, the influence of methimazole, carbimazole, and the concentration of the supporting electrolyte on the kinetics and mechanism of zinc electroreduction on a mercury electrode was compared and ...
Jolanta Nieszporek   +2 more
doaj   +1 more source

Error in diagnosis and medication prescription in a psychiatric patient with a history of hypothyroidism: A case report [PDF]

open access: yesفصلنامه ابن سینا
This article reports a case of a medical error in the diagnosis and treatment of thyroid disease in a 29-year-old man hospitalized following a suicide attempt and diagnosed with severe depression.
Azam Sharifi Rizi   +2 more
doaj  

Ameliorative Effects of Taurine Against Methimazole-Induced Cytotoxicity in Isolated Rat Hepatocytes

open access: yes, 2012
Methimazole is used as an antithyroid drug to control the symptoms of hyperthyroidism and maintain patients in a euthyroid state. Administration of this drug is associated with agranulocytosis and hepatotoxicity, which are the two most significant ...
Reza HEIDARI   +2 more
core   +1 more source

Hyperthyroidism, methimazole and alkaline phosphatase

open access: yes, 1993
Les auteurs rapportent le cas d'une patiente hyperthyroïdienne présentant un taux élevé de phosphatase alcaline.
OKOLICSANYI (L.)   +5 more
core  

The immunomodulatory effect of methimazole on inbred mice. [PDF]

open access: yes, 1992
by Tsui Kai Wing.Thesis (M.Phil.)--Chinese University of Hong Kong, 1992.Includes bibliographical references (leaves 100-112).Abstract --- p.iAcknowledgements --- p.iiiList of Abbreviations --- p.ivContents --- p.vChapter Chapter 1 --- General ...

core  

The Effects of Anti-thyroid Drugs on Lipoproteins and Insulin Resistance in Graves’ Disease: A Randomized Clinical Trial

open access: yesJournal of Lipid and Atherosclerosis
Objective Graves’ disease (GD) is characterized by thyroid overactivity. Anti-thyroid drugs (ATDs), such as propylthiouracil (PTU) and methimazole (MMI), are commonly used for GD treatment, and studies have suggested a link between these drugs and ...
Wismandari Wisnu   +8 more
doaj   +1 more source

Methimazole-Induced Agranulocytosis: A Clinical Case Report

open access: yesEndocrinology Insights
Introduction: Antithyroid drugs are generally safe. However, rare but life-threatening side effects, such as agranulocytosis, may occur. Case Presentation: We present the case of a 70-year-old woman with subclinical hyperthyroidism, previously
João Menino   +5 more
doaj   +1 more source

Methimazole interferes with the progression of experimental autoimmune myocarditis in rats

open access: yes, 2001
In order to ascertain whether methimazole, a drug commonly used for the treatment of hyperthyroidism, interferes with the progression of autoimmune-mediated myocardial injury, we investigated the effect of methimazole on experimental autoimmune ...
Matsui, S   +4 more
core  

Home - About - Disclaimer - Privacy